TIZANDINE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Directrx. The primary component is Tizanidine Hydrochloride.
| Product ID | 61919-811_87d9280d-684f-f5f5-e053-2a95a90aefdf |
| NDC | 61919-811 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TIZANDINE |
| Generic Name | Tizandine |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-05-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA091283 |
| Labeler Name | DirectRX |
| Substance Name | TIZANIDINE HYDROCHLORIDE |
| Active Ingredient Strength | 2 mg/1 |
| Pharm Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-05-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA091283 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2020-01-08 |
| Marketing Category | ANDA |
| Application Number | ANDA091283 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-08-19 |
| Marketing Category | ANDA |
| Application Number | ANDA091283 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-05-01 |
| Marketing Category | ANDA |
| Application Number | ANDA091283 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA091283 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-08-13 |
| Ingredient | Strength |
|---|---|
| TIZANIDINE HYDROCHLORIDE | 2 mg/1 |